Feline Focus 5This page contains information on Feline Focus 5 for veterinary use.
The information provided typically includes the following:
- Feline Focus 5 Indications
- Warnings and cautions for Feline Focus 5
- Direction and dosage information for Feline Focus 5
Feline Focus 5This treatment applies to the following species:
Feline Leukemia-rhinotracheitis-calici-panleukopenia-chlamydia Psittaci Vaccine, Modified Live Virus And Chlamydia And Killed Virus
For veterinary use only. For use in cats only.
Product DescriptionFELINE FOCUS™ 5 vaccine is a combination vaccine that unites the benefits of FELINE FOCUS 4 and FELINE FOCUS FeLV in one vaccination. FELINE FOCUS 4 vaccine is a modified live virus and chlamydia vaccine for the vaccination of healthy cats as an aid in the prevention of disease caused by feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci. FELINE FOCUS FeLV vaccine is recommended for the vaccination of healthy cats as an aid in the prevention of lymphoid tumors caused by, and diseases associated with, feline leukemia virus (FeLV) infection. Vaccination with this product prevents persistent viremia in cats exposed to virulent feline leukemia virus. FeLV contains a tissue culture derived feline leukemia virus, Subgroups A and B. The virus has been chemically inactivated and combined with a proprietary adjuvant designed to enhance the immune response.
Feline Focus 5 Dosage And AdministrationTwo doses are required for primary immunization.
Initial VaccinationInject 1 dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older.
Second VaccinationInject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination. Annual revaccination with one dose is recommended. Prior to use, warm the FELINE FOCUS FELV to room temperature and shake well. Transfer contents of the FELINE FOCUS FELV vial to the FELINE FOCUS 4 vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.
PrecautionsStore at 35°-45°F (2°-7°C). Do not freeze. Use new, non-chemically sterilized, needles and syringes. Do not mix with other vaccines. Burn vaccine containers and all unused contents.
WarningsDo not vaccinate pregnant cats. Contains gentamicin and amphotericin B as preservatives. The use of this biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions.
AntidoteEpinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction. Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas. It is important to realize that certain conditions and events may cause some cats to be unable to develop or maintain an adequate immune response following FeLV vaccination. Prior exposure to the disease, or disease latency, are conditions in which vaccination will not alter the course of the disease. Therefore, diagnostic testing of all cats for FeLV antigen prior to vaccination is recommended. Also, vaccination with this product will not offer cross-protection against feline immunodeficiency (FIV), another feline retrovirus. It is important to advise the cat owner of these situations prior to vaccination.
Produced by: Schering-Plough Animal Health Corp., Omaha, NE 68103 USA
U.S. Vet. License No. 165A
Distributed by: Peak Marketing, P.O. Box 279, Blue Springs, MO 64013 USA
1 800 821-5570
1 Dose/Rehydrate to 1mL
P.O. BOX 279, 100 S.E. MAGELLAN DRIVE, BLUE SPRINGS, MO, 64014
|Every effort has been made to ensure the accuracy of the Feline Focus 5 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Feline Focus 5 product label or package insert.|
Copyright © 2015 North American Compendiums. Updated: 2015-04-03